Artificial intelligence research in the COVend COVID-19 clinical trial project

    Tutkimustuotos: ArtikkeliTieteellinen

    4 Lataukset (Pure)

    Abstrakti

    The COVend project aims at delivering a new effective therapy, FX06, against the SARS-CoV-2 virus infection for the management of the COVID-19 disease in hospitals. Nine of the 17 partners of the project consortium are hospitals responsible for collecting study subjects and administering the FX06 therapy to the patients. Although the clinical trial (IXION) has the main role in the project, the project has also a work package which develops and applies artificial intelligence (AI) methods to the data collected during the 28-day study period from the patients receiving the therapy. The AI work package applies exploratory data analysis methods to find patterns and profiles of the patients. Combined with the data about treatment methods and patient outcomes, the aim is to provide decision support for the therapy intervention in the later stage of the project.
    AlkuperäiskieliEnglanti
    Sivut230-234
    Sivumäärä5
    JulkaisuFinnish Journal of eHealth and eWelfare
    Vuosikerta15
    Numero2
    DOI - pysyväislinkit
    TilaJulkaistu - 20 huhtik. 2023
    OKM-julkaisutyyppiB1 Kirjoitus tieteellisessä aikakausilehdessä

    Sormenjälki

    Sukella tutkimusaiheisiin 'Artificial intelligence research in the COVend COVID-19 clinical trial project'. Ne muodostavat yhdessä ainutlaatuisen sormenjäljen.

    Siteeraa tätä